Okanagan Clinical Trials is looking for individuals aged between 19 and 80, who are currently experiencing chronic nerve pain ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

GLP-1 (glucagon-like peptide) medications, such as Ozempic and Wegovy, have seen a surge in popularity over the past few ...

With 30,000+ Gluco Extend users (Official Source) already integrating it into their daily routines, many are wondering what makes this blood sugar support formula so different from everything else on ...

Diabetes Alert Day recognizes diabetes and its complications. One condition, known as diabetic peripheral neuropathy, affects ...

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Endometriosis is a condition where tissue similar to the lining of the womb starts to grow in other places, such as the ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Diabetic foot ulcers (DFUs) remain a significant health concern worldwide, contributing to considerable morbidity, disability ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India, marking its entry into a rapidly growing market.